Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

589 ARTÍCULOS , VIENDO DEL 511 AL 525

Discontinuation of cholinesterase inhibitor treatment in institutionalised patients with advanced dementia

García-García R, Calleja-Hernández MÁ.

Eur J Hosp Pharm. 2022 May;29(3):145-150. doi: 10.1136/ejhpharm-2019-002106. Epub 2020 Jul 28.

Pharmacogenetic studies in Alzheimer disease

Zúñiga Santamaría T, Yescas Gómez P, Fricke Galindo I, González González M, Ortega Vázquez A, López López M.

Neurologia (Engl Ed). 2022 May;37(4):287-303. doi: 10.1016/j.nrleng.2018.03.022. Epub 2020 Jun 1.

A Review on Chitosan in Drug Delivery for Treatment of Neurological and Psychiatric Disorders

Shayganfard M.

Curr Pharm Biotechnol. 2022;23(4):538-551. doi: 10.2174/1389201022666210622111028.

Implication of Covid-19 on Neurological Complications with Specific Emphasis on Alzheimer's and Parkinson's Disease

Sood A, Goyal R, Singh H, Behl T, Arora S, Saini B, Kaur R.

CNS Neurol Disord Drug Targets. 2022;21(3):235-245. doi: 10.2174/1871527320666210820092817.

Squalamine and trodusquemine: two natural products for neurodegenerative diseases, from physical chemistry to the clinic

Limbocker R, Errico S, Barbut D, Knowles TPJ, Vendruscolo M, Chiti F, Zasloff M.

Nat Prod Rep. 2022 Apr 20;39(4):742-753. doi: 10.1039/d1np00042j.

A Brewed Awakening: Neuropsychiatric Effects of Caffeine in Older Adults

Kim E, Robinson NM, Newman BM.

Clin Geriatr Med. 2022 Feb;38(1):133-144. doi: 10.1016/j.cger.2021.07.009.

Current Research on Pro-drug Therapies for Parkinson's and Alzheimer's Disease

Huo C, Wu L, Jiang Z, Yang J, Wang Z, Li Y, Qian S.

Med Chem. 2022;18(6):655-666. doi: 10.2174/1573406418666211130150821.

Challenges of repurposing tetracyclines for the treatment of Alzheimer's and Parkinson's disease

Markulin I, Matasin M, Turk VE, Salković-Petrisic M.

J Neural Transm (Vienna). 2022 Jun;129(5-6):773-804. doi: 10.1007/s00702-021-02457-2. Epub 2022 Jan 4.

Neurobiological Promises of the Bitter Diterpene Lactone Andrographolide

Hossain R, Quispe C, Herrera-Bravo J, Beltrán JF, Islam MT, Shaheen S, Cruz-Martins N, Martorell M, Kumar M, Sharifi-Rad J, Ozdemir FA, Setzer WN, Alshehri MM, Calina D, Cho WC.

Oxid Med Cell Longev. 2022 Feb 1;2022:3079577. doi: 10.1155/2022/3079577. eCollection 2022.

"Focused Ultrasound-mediated Drug Delivery in Humans - a Path Towards Translation in Neurodegenerative Diseases"

Wasielewska JM, White AR.

Pharm Res. 2022 Mar;39(3):427-439. doi: 10.1007/s11095-022-03185-2. Epub 2022 Mar 7.

Pharmacological considerations for treating neuroinflammation with curcumin in Alzheimer's disease

Zhou X, Venigalla M, Raju R, Münch G.

J Neural Transm (Vienna). 2022 Jun;129(5-6):755-771. doi: 10.1007/s00702-022-02480-x. Epub 2022 Mar 16.

Modifying the diet and gut microbiota to prevent and manage neurodegenerative diseases

Gates EJ, Bernath AK, Klegeris A.

Rev Neurosci. 2022 Mar 21;33(7):767-787. doi: 10.1515/revneuro-2021-0146. Print 2022 Oct 26.

A Review on the Arylpiperazine Derivatives as Potential Therapeutics for the Treatment of Various Neurological Disorders

Kumar B, Kumar N, Thakur A, Kumar V, Kumar R, Kumar V.

Curr Drug Targets. 2022;23(7):729-751. doi: 10.2174/1389450123666220117104038.

Meta-analysis of genome-wide association studies identifies ancestry-specific associations underlying circulating total tau levels

Sarnowski C, Ghanbari M, Bis JC, Logue M, Fornage M, Mishra A, Ahmad S, Beiser AS, Boerwinkle E, Bouteloup V, Chouraki V, Cupples LA, Damotte V, DeCarli CS, DeStefano AL, Djoussé L, Fohner AE, Franz CE, Kautz TF, Lambert JC, Lyons MJ, Mosley TH, Mukamal KJ, Pase MP, Portilla Fernandez EC, Rissman RA, Satizabal CL, Vasan RS, Yaqub A, Debette S, Dufouil C, Launer LJ, Kremen WS, Longstreth WT, Ikram MA, Seshadri S.

Commun Biol. 2022 Apr 8;5(1):336. doi: 10.1038/s42003-022-03287-y.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias